AXSM
Axsome Therapeutics, Inc. Health Care Pharmaceutical Preparations Russell 3000
$144.43Close
$7.3BMarket cap
$133.15 – $255.1752-week range
Nov 2, 2026Next report · before the open
Highlights
Cautions
- Not in an uptrend 1 of 8 trend conditions
- Lagging the market RS 14 · weaker than 86% of stocks over 12 months
- Far from its high 43% below its 52-week high
- Distribution down-day volume 2.6× up-day volume over 50 sessions
- Results soon Nov 2, 2026, in 1 day
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
43%
1wk
down 0.4%
price change
1mo
down 21.7%
price change
12-month return
up 8%
market up 11% ·
its own down 3%
F-score
—
— Not assessed
Altman Z
5.17
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
83.2×
price / book
Earnings yield
down 2.3%
EBIT / enterprise value
Cheaper than
13%
of the market · expensive
Revenue growth
up 66%
year on year
EPS growth
—
latest quarter
Sales growth
up 46%
latest quarter · -12 pts
ROE
down 252%
return on equity
Free cash margin
down 15%
-$93.9M FCF
D/E
1.33
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Piotroski tests
Repair signals
- Long-term debt down 35% ($0.2B → $0.1B)
Trade setup
ATR%
5.0%
$7.19 a day · 2×ATR $130.05
RS
14 / 99
vs the universe
Trend
1 / 8
trend template
Relative volume
2.8×
vs 50-day average
Up/down volume
0.39
50 sessions
Implied move
—
no option chain · report Nov 2, 2026
Trend template · 1 of 8
- 150-day average above the 200-day: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 4.6% over the year, from 49m to 51m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 10, 2026
Results reaction
Aug 10, 2026+2% vs market2 sessions after results
Financials
- Net -29%
- Free cash -15%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | $50.0M | $270.6M | $385.7M | $638.5M |
| Gross margin | — | — | 90% | — | — | — |
| Operating income | -$99.1M | -$124.7M | -$179.8M | -$231.8M | -$280.6M | -$166.8M |
| Net income | -$102.9M | -$130.4M | -$187.1M | -$239.2M | -$287.2M | -$183.2M |
| Net margin | — | — | -374% | -88% | -74% | -29% |
| Earnings per share | -$2.77 | -$3.47 | -$4.60 | -$5.27 | -$5.99 | -$3.68 |
| Free cash flow | -$78.5M | -$108.5M | -$117.2M | -$145.7M | -$128.7M | -$93.9M |
| Free cash margin | — | — | -234% | -54% | -33% | -15% |
| Cash | $183.9M | $86.5M | $200.8M | $386.2M | $315.4M | $322.9M |
| Long-term debt | $48.3M | $49.1M | $94.3M | $178.1M | $180.7M | $117.7M |
| Shareholders' equity | $113.8M | $15.6M | $109.6M | $191.0M | $57.0M | $88.3M |
| Shares outstanding | 37.37m | 37.82m | 43.50m | 47.35m | 48.67m | 50.88m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 10, 2026 | Quarterly ↗ | Jun 30, 2026 | 41d |
| May 4, 2026 | Quarterly ↗ | Mar 31, 2026 | 34d |
| Feb 23, 2026 | Annual ↗ | Dec 31, 2025 | 54d |
| Nov 3, 2025 | Quarterly ↗ | Sep 30, 2025 | 34d |
| Aug 4, 2025 | Quarterly ↗ | Jun 30, 2025 | 35d |
| May 5, 2025 | Quarterly ↗ | Mar 31, 2025 | 35d |
| Feb 18, 2025 | Annual ↗ | Dec 31, 2024 | 49d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 5, 2024 | Quarterly ↗ | Jun 30, 2024 | 36d |
| May 6, 2024 | Quarterly ↗ | Mar 31, 2024 | 36d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
| Nov 6, 2023 | Quarterly ↗ | Sep 30, 2023 | 37d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 10, 2026 | Results · Other events ↗ |
| Jul 15, 2026 | Other events ↗ |
| Jun 9, 2026 | Director or officer change ↗ |
| Jun 9, 2026 | Shareholder vote ↗ |
| Jun 3, 2026 | Other events ↗ |
| May 4, 2026 | Results · Other events ↗ |
| Apr 30, 2026 | Other events ↗ |
| Apr 1, 2026 | Other events ↗ |
| Feb 23, 2026 | Results ↗ |
| Feb 17, 2026 | Other events ↗ |
| Jan 12, 2026 | Results · Other events ↗ |
| Dec 31, 2025 | Other events ↗ |